DC
Daxaben Chandrakant Prajapati
About Daxaben Chandrakant Prajapati
Data last updated:
Daxaben Chandrakant Prajapati is a Designated Partner at J And H Control Systems Llp (since 2020) and Designated Partner at Acura Pharma Llp (since 2025). The companies operate in Machinery and Equipment. The largest current company by reported revenue is J And H Control Systems Llp at ₹9.78 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 J And H Control Systems Llp AAL-8517 | Designated Partner | 27 Jul 2020 | 2018 | ₹9.78 Cr (FY 2021) | Active |
| Acura Pharma Llp ACR-0438 | Designated Partner | 03 Sep 2025 | 2025 | Active |
Board colleagues of Daxaben Chandrakant Prajapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vishalkumar Jagdishbhai Gurjar | 08025177 | J And H Control Systems Llp | Designated Partner |
| Harshil Rinaben Prajapati | 10613466 | Acura Pharma Llp | Designated Partner |
| Nilam Amitkumar Prajapati | 11276962 | Acura Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Daxaben Chandrakant Prajapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daxaben Chandrakant Prajapati
Daxaben Chandrakant Prajapati currently holds 2 directorships: J And H Control Systems Llp (Designated Partner, since 27 Jul 2020, revenue ₹9.78 Cr (FY 2021)); Acura Pharma Llp (Designated Partner, since 03 Sep 2025).
Daxaben Chandrakant Prajapati was first appointed on 27 Jul 2020 as Designated Partner at J And H Control Systems Llp. The most recent appointment on record is 03 Sep 2025 at Acura Pharma Llp.
The current boards of Daxaben Chandrakant Prajapati's companies include Vishalkumar Jagdishbhai Gurjar (J And H Control Systems Llp), Harshil Rinaben Prajapati (Acura Pharma Llp), Nilam Amitkumar Prajapati (Acura Pharma Llp).